Sickle Cell Anaemia

Overview – Sickle Cell Anaemia

Sickle cell anaemia is an inherited haemoglobinopathy caused by a structural mutation in the beta-globin gene. It leads to the formation of abnormal haemoglobin (HbS), which polymerises under low oxygen tension, distorting red blood cells into a sickle shape. These cells are rigid, poorly deformable, and prone to haemolysis and vascular occlusion. Sickle cell anaemia is most common in Afro-Caribbean populations and causes chronic anaemia, pain crises, and multiple systemic complications. Early diagnosis and preventive care are key to managing this lifelong condition.


Definition

  • A genetic disorder of haemoglobin structure
  • Characterised by production of HbS instead of normal HbA
  • Leads to sickle-shaped red cells, chronic haemolysis, and vaso-occlusive complications

Aetiology

  • Autosomal recessive inheritance
  • Point mutation in β-globin gene (Glu → Val substitution)
  • Prevalent in African, Afro-Caribbean, and Mediterranean populations

Pathophysiology

  • Under low oxygen tension, HbS becomes insoluble
  • Polymerisation of HbS → RBCs assume sickle shape
  • Sickle cells are:
    • Rigid
    • Sticky
    • Poorly deformable
  • Consequences:
    • Capillary obstruction → local ischaemia and infarction
    • Haemolysis → chronic anaemia and elevated bilirubin

Microscopy

  • Sickle-shaped red cells on peripheral smear
  • Target cells and nucleated RBCs may also be seen
  • Evidence of chronic haemolysis (e.g. ↑ reticulocytes)

Clinical Features

Anaemia Symptoms

  • Fatigue
  • Pallor
  • Exertional dyspnoea

Vaso-Occlusive Symptoms

  • Pain crises (most characteristic feature)
    • Sudden, severe pain due to ischaemia
    • Typically affects chest, abdomen, bones, and joints
    • May occur infrequently or multiple times per year
  • Dactylitis: swelling of hands and feet (common in infants)
  • Frequent infections (due to functional asplenia)
  • Delayed growth and puberty

Treatment

  • No definitive cure (except potential stem cell transplant)
  • Hydroxyurea: increases HbF and reduces pain crisis frequency
  • L-glutamine: reduces frequency and severity of crises
  • Analgesia during pain episodes
  • Vaccination and antibiotic prophylaxis (e.g. penicillin) to prevent infections
  • Folic acid supplementation for red cell turnover
  • Blood transfusions in selected cases (e.g. stroke prevention)
  • Bone marrow transplant: potentially curative in children

Complications

  • Stroke
  • Pulmonary hypertension
  • Heart failure
  • Renal disease
  • Retinopathy and blindness
  • Leg ulcers
  • Avascular necrosis of bone
  • Gallstones (from chronic haemolysis)
  • Priapism
  • Delayed growth and puberty
  • Recurrent miscarriage or complications in pregnancy

Summary – Sickle Cell Anaemia

Sickle cell anaemia is an inherited disorder leading to sickling of red cells under low oxygen, causing haemolysis and painful vaso-occlusive crises. It is common in individuals of Afro-Caribbean descent and presents with anaemia, recurrent pain episodes, and systemic complications. Management focuses on crisis prevention, symptom relief, and long-term organ protection. For a broader context, see our Blood & Haematology Overview page.

Shopping Cart
Scroll to Top